Rafferty Asset Management
NGNE icon

Rafferty Asset Management’s Neurogene NGNE Stock Holding History

Rafferty Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,813
Closed -$335K – 1293
2021
Q2 		$335K Sell
1,813
-1,682
-48% -$372K ﹤0.01% 1153
2021
Q1 		$860K Buy
+3,495
New +$893K 0.01% 807

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Rafferty Asset Management's NGNE Position: Q3 2021 in Review

Rafferty Asset Management sold out of Neurogene (NGNE) in Q3 2021, closing a stake of 1,813 shares — an estimated $335K sold.

Rafferty Asset Management first reported a position in NGNE in Q1 2021 and held it in 2 quarters. The position peaked at $860K in Q1 2021. 85 funds tracked by Wall St. Rank hold NGNE as of Q3 2021.

  • Rafferty Asset Management reported no remaining Neurogene position as of Q3 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 1,813 Neurogene shares in Q3 2021, an estimated $335K.
  • Rafferty Asset Management first reported a position in Neurogene in Q1 2021 and held it in 2 quarters.
  • Rafferty Asset Management's Neurogene position peaked at $860K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Neurogene as of Q3 2021.

Based on Rafferty Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.